跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,940 条关于
“Alkem Laboratories Ltd.”
全部
10,940
临床试验
1,883
药物
1,643
机构
4,414
资讯
3,000
10个月前
Alkem Foundation Partners with IIT Bombay to Establish India's First Immunotherapy Research Centre
2年前
Enzene Biosciences Establishes $50 Million New Jersey Manufacturing Facility with Continuous Biologics Platform
去年
Esperion Secures Patent Protection for NEXLETOL Until 2040 Through Settlement with Micro Labs
7个月前
Alkem Laboratories Enters Cardiovascular Device Market with €99.4 Million Occlutech Acquisition
去年
PromarkerEso Blood Test Shows 94% Accuracy in Esophageal Cancer Detection
12个月前
Alkem Laboratories Launches Affordable Pertuzumab Biosimilar for HER2-Positive Breast Cancer in India
去年
NPPA Sets Retail Prices for 84 Drugs Including Empagliflozin Combinations Following Patent Expiry
前天
Alkem Launches NeuCeno (cenobamate) in India, First Availability of the Anti-Seizure Drug for Partial-Onset Seizures
去年
FDA Approves 25 First-Time Generic Drugs in First Half of 2025, Expanding Access to Critical Therapies
去年
CDSCO Panel Approves Phase III Trial of Semaglutide Injection with Enhanced Retinal Monitoring
第 1 页,共 300 页
上一页
下一页